Valeo Financial Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-431
| Closed | -$22K | – | 1684 |
|
|
2020
Q2 | $22K | Hold |
431
| – | – | ﹤0.01% | 964 |
|
|
2020
Q1 | $22K | Sell |
431
-75
| -15% | -$3.83K | ﹤0.01% | 834 |
|
|
2019
Q4 | $31K | Sell |
506
-295
| -37% | -$18.1K | ﹤0.01% | 790 |
|
|
2019
Q3 | $48K | Hold |
801
| – | – | 0.01% | 606 |
|
|
2019
Q2 | $68K | Sell |
801
-28
| -3% | -$2.38K | 0.01% | 520 |
|
|
2019
Q1 | $79K | Buy |
829
+549
| +196% | +$52.3K | 0.01% | 455 |
|
|
2018
Q4 | $20K | Hold |
280
| – | – | ﹤0.01% | 702 |
|
|
2018
Q3 | $22K | Hold |
280
| – | – | ﹤0.01% | 740 |
|
|
2018
Q2 | $24K | Hold |
280
| – | – | ﹤0.01% | 702 |
|
|
2018
Q1 | $23K | Hold |
280
| – | – | ﹤0.01% | 671 |
|
|
2017
Q4 | $16K | Hold |
280
| – | – | ﹤0.01% | 717 |
|
|
2017
Q3 | $13K | Buy |
+280
| New | +$13K | ﹤0.01% | 632 |
|